[1]
“Global Longitudinal Strain of Chronic Granulocytic Leukemia Patients treated with Imatinib and Nilotinib”, IJIHS, vol. 9, no. 2, pp. 49–54, Oct. 2021, doi: 10.15850/ijihs.v9n2.2217.